A new Hong Kong nasal spray could cut stroke impairment risk by over 80 percent

Hong Kong researchers have developed the world’s first nasal spray that can be administered as first aid treatment to ischemic stroke sufferers, significantly reducing their risk of brain damage and other stroke-related complications.  At a press conference yesterday, the team introduced the “NanoPowder nasal spray,” which was jointly developed by the University of Hong Kong’s …